Abbott Corp. (ABT) - Long-Term Debt to Capital

Abbott Laboratories (ABT) develops automated diagnostic systems and health-tracking gadgets, reducing manual labor for medical professionals. This price chart on GURU.Markets shows the metric at 0.61. Business stability is driven by four autonomous segments—ranging from devices and tests to nutritionals and generics—creating a benchmark balance and minimizing financial risks.

For the non-cyclical business of Abbott Laboratories (ABT), which demonstrates high resilience to macroeconomic shocks, this indicator serves as a measure of long-term financial autonomy. By analyzing the long-term debt-to-equity ratio, an investor assesses the proportion of borrowed funds with maturities exceeding one year within the financing structure, where a decreasing coefficient confirms stability, although excessive conservatism may signal a slowdown in expansion.